Sulzer Dental Introduces Tutogen's Puros and Navigraft in France and Germany
CLIFTON, N.J.--(BUSINESS WIRE)--June 7, 2001--Tutogen Medical Inc. (AMEX: TTG), is pleased to announce that beginning in June, Sulzer Dental Inc. (formerly Sulzer Calcitek), will introduce Puros(TM), Tutogen's human derived bone grafting products in France, and Navigraft(TM), Tutogen's bovine bone grafting products in Germany.
Tutogen Medical plans to seek additional registration for the sale of bovine material in France in conjunction with the launch of Puros. There has been tremendous growth in Puros sales since Sulzer Dental introduced it in the U.S. Sulzer Dental, (www.sulzerdental.com) with its recent acquisition of Paragon Implant Company is now among the top three dental implant companies in the world.
Steven Hanson, President of Sulzer Dental, remarked, "I am very pleased to be the exclusive distributor of Tutogen's Tutoplast(TM) dental products. We look forward to introducing their human and bovine products in the course of the next few days."
Sulzer Dental began marketing Puros in February and has experienced a strong demand for the bone-grafting product. Sulzer Dental expects to continue to increase sales and obtain a large portion of the dental bone graft market. Market research estimates the U.S. dental bone grafting market to be approximately USD $30 million. The European market is also estimated to be around USD $30 million.
Manfred Krueger, President of Tutogen commented, "We believe that the dental implant market represents one of the largest untapped biologic implant opportunities in the field of tissue replacement. As a solution for the replacement of lost teeth, there is no better choice. As the costs for implants comes down, their superior performance as compared to conventional solutions in the form of bridges and partial dentures will drive, I believe, a significant increase in demand for biologic implants. We are also working with Sulzer Dental to develop additional Tutoplast(TM) dental products." |
